• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

百年回顾;冯·贝林和北里柴三郎1890年关于破伤风抗毒素的论文及相关进展。

A centennial review; the 1890 tetanus antitoxin paper of von Behring and Kitasato and the related developments.

作者信息

Kantha S S

机构信息

Department of Physiology and Biochemistry, Medical College of Pennsylvania, Philadelphia.

出版信息

Keio J Med. 1991 Mar;40(1):35-9. doi: 10.2302/kjm.40.35.

DOI:10.2302/kjm.40.35
PMID:2046211
Abstract

The significance of the 1890 tetanus antitoxin paper by von Behring and Kitasato in the development of a new discipline, immunology, is reviewed. The possible reasons why Kitasato lost the first Nobel Prize for medicine to von Behring are presented. These are as follows: (1) The Nobel selection committee literally interpreted Alfred Nobel's will to award the prize to "the person who has made the most important discovery." (2) In the late 19th century, diphtheria was a serious contagious disease which claimed many thousands of lives in the Europe and America; and von Behring's solely authored paper on diphtheria antitoxin clinched the award for him. (3) The merit of tetanus antitoxin to humans, which was the focal point of the 1890 paper on tetanus antitoxin jointly authored by von Behring and Kitasato, was not recognized at the time of the award in 1901; it became apparent only during the First World War.

摘要

回顾了1890年冯·贝林和北里柴三郎关于破伤风抗毒素的论文在新学科免疫学发展中的意义。阐述了北里柴三郎未能从冯·贝林手中获得首届诺贝尔医学奖的可能原因。具体如下:(1)诺贝尔评选委员会从字面上解读了阿尔弗雷德·诺贝尔的遗嘱,将奖项授予“做出最重要发现的人”。(2)在19世纪末,白喉是一种严重的传染病,在欧美夺去了成千上万人的生命;冯·贝林关于白喉抗毒素的独著论文为他赢得了该奖项。(3)破伤风抗毒素对人类的价值,这是1890年冯·贝林和北里柴三郎共同撰写的关于破伤风抗毒素论文的重点,在1901年颁奖时并未得到认可;直到第一次世界大战期间才变得明显。

相似文献

1
A centennial review; the 1890 tetanus antitoxin paper of von Behring and Kitasato and the related developments.百年回顾;冯·贝林和北里柴三郎1890年关于破伤风抗毒素的论文及相关进展。
Keio J Med. 1991 Mar;40(1):35-9. doi: 10.2302/kjm.40.35.
2
The legacy of von Behring and Kitasato.冯·贝林和北里柴三郎的遗产。
Immunol Today. 1992 Sep;13(9):374. doi: 10.1016/0167-5699(92)90177-9.
3
Behring's discovery of diphtheria and tetanus antitoxins.贝林对白喉和破伤风抗毒素的发现。
Immunol Today. 1992 May;13(5):188-90. doi: 10.1016/0167-5699(92)90125-Q.
4
Emil von Behring: translational medicine at the dawn of immunology.埃米尔·冯·贝林:免疫学黎明时期的转化医学。
Nat Rev Immunol. 2017 Jun;17(6):341-343. doi: 10.1038/nri.2017.37. Epub 2017 Apr 10.
5
The Nobel Prize for Medicine or Physiology, 1901, awarded to Emil Adolf von Behring.1901年诺贝尔生理学或医学奖授予埃米尔·阿道夫·冯·贝林。
Scand J Immunol. 1989 Jul;30(1):3-12.
6
[Behring's personal papers--Behring's lives].[贝林的私人文件——贝林的人生]
Ber Wiss. 2014 Sep;37(3):216-39. doi: 10.1002/bewi.201401680.
7
Who was... Emil von Behring?谁是……埃米尔·冯·贝林?
Biologist (London). 2001 Jun;48(3):136-7.
8
Emil von Behring (1854-1917): Medicine's first Nobel laureate.埃米尔·冯·贝林(1854 - 1917):医学领域的首位诺贝尔奖获得者。
Singapore Med J. 2011 Jan;52(1):1-2.
9
[Emil von Bering and the development of German immunology].[埃米尔·冯·贝林与德国免疫学的发展]
Med Welt. 1979;30(48):1795-801.
10
Emil von Behring and the last hundred years of immunology.埃米尔·冯·贝林与免疫学的百年历程
Indian J Physiol Pharmacol. 2001 Oct;45(4):389-94.

引用本文的文献

1
The Quest for Antibodies and Other Acquired Immune Receptors: A Historical Perspective.探索抗体及其他获得性免疫受体:历史视角
Int J Immunogenet. 2025 Jun;52(3):125-134. doi: 10.1111/iji.12712. Epub 2025 May 8.
2
Diphtheria antitoxin treatment: from pioneer to neglected.白喉抗毒素治疗:从先驱到被忽视
Mem Inst Oswaldo Cruz. 2025 Jan 20;120:e240214. doi: 10.1590/0074-02760240214. eCollection 2025.
3
Development of Effective Medical Countermeasures Against the Main Biowarfare Agents: The Importance of Antibodies.针对主要生物战剂的有效医学应对措施的研发:抗体的重要性
Microorganisms. 2024 Dec 18;12(12):2622. doi: 10.3390/microorganisms12122622.
4
Transforming vaccinology.疫苗学的变革。
Cell. 2024 Sep 19;187(19):5171-5194. doi: 10.1016/j.cell.2024.07.021.
5
Using next generation antimicrobials to target the mechanisms of infection.使用新一代抗菌药物来针对感染机制。
NPJ Antimicrob Resist. 2023;1(1):11. doi: 10.1038/s44259-023-00011-6. Epub 2023 Sep 22.
6
Research Progress on Small Molecular Inhibitors of the Type 3 Secretion System.III 型分泌系统小分子抑制剂的研究进展。
Molecules. 2022 Nov 30;27(23):8348. doi: 10.3390/molecules27238348.
7
Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections.抗病毒感染单克隆抗体发现与开发的最新进展
Biomedicines. 2022 Aug 2;10(8):1861. doi: 10.3390/biomedicines10081861.
8
Similarity and Diversity of Presynaptic Molecules at Neuromuscular Junctions and Central Synapses.突触前分子在神经肌肉接头和中枢突触中的相似性和多样性。
Biomolecules. 2022 Jan 21;12(2):179. doi: 10.3390/biom12020179.
9
Intravenous Immune Globulin Uses in the Fetus and Neonate: A Review.静脉注射免疫球蛋白在胎儿和新生儿中的应用:综述
Antibodies (Basel). 2020 Nov 4;9(4):60. doi: 10.3390/antib9040060.
10
Guidelines for animal exercise and training protocols for cardiovascular studies.动物运动和心血管研究训练方案指南。
Am J Physiol Heart Circ Physiol. 2020 May 1;318(5):H1100-H1138. doi: 10.1152/ajpheart.00697.2019. Epub 2020 Mar 20.